S&P 500 Futures
(0.12%) 5 333.50 points
Dow Jones Futures
(0.03%) 40 148 points
Nasdaq Futures
(0.16%) 18 665 points
Oil
(-0.37%) $79.76
Gas
(0.53%) $2.64
Gold
(1.30%) $2 448.80
Silver
(3.11%) $32.23
Platinum
(0.31%) $1 093.40
USD/EUR
(0.05%) $0.920
USD/NOK
(0.01%) $10.68
USD/GBP
(0.03%) $0.787
USD/RUB
(-0.31%) $90.68

Realtime updates for Isofol Medical AB (publ) [ISOFOL.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated20 May 2024 @ 04:59

-1.22% SEK 0.730

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 04:59):

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer...

Stats
Today's Volume 155 501
Average Volume 596 441
Market Cap 117.91M
EPS SEK0 ( 2024-05-08 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -3.84
ATR14 SEK0.00700 (0.96%)

Volume Correlation

Long: 0.08 (neutral)
Short: 0.35 (neutral)
Signal:(56.867) Neutral

Isofol Medical AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Isofol Medical AB (publ) Correlation - Currency/Commodity

The country flag 0.67
( moderate )
The country flag 0.70
( moderate )
The country flag 0.00
( neutral )
The country flag 0.77
( moderate )
The country flag 0.00
( neutral )
The country flag -0.53
( weak negative )

Isofol Medical AB (publ) Financials

Annual 2023
Revenue: SEK721 000
Gross Profit: SEK-41.88M (-5 808.04 %)
EPS: SEK-0.230
FY 2023
Revenue: SEK721 000
Gross Profit: SEK-41.88M (-5 808.04 %)
EPS: SEK-0.230
FY 2022
Revenue: SEK12.80M
Gross Profit: SEK-165.71M (-1 294.89 %)
EPS: SEK-0.970
FY 2021
Revenue: SEK22.41M
Gross Profit: SEK0.00 (0.00 %)
EPS: SEK-1.909

Financial Reports:

No articles found.

Isofol Medical AB (publ) Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Isofol Medical AB (publ)

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators